Results 161 to 168 of about 9,247 (168)

Daratumumab

Reactions Weekly, 2016
openaire   +1 more source

Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA)

Clinical Chemistry and Laboratory Medicine, 2016
Hans Jacobs, Henny Otten
exaly  

Daratumumab for the treatment of AL amyloidosis

Leukemia and Lymphoma, 2019
Morie Gertz, M Hasib Sidiqi
exaly  

Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2020
Isabel Krsnik, Maria Teresa Cibeira Lopez, Ramon Lecumberri   +2 more
exaly  

MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins

Clinica Chimica Acta, 2019
Katie Thoren
exaly  

Daratumumab Single Agent and Daratumumab Plus Pomalidomide and Dexametasone in Relapsed/Refractory Multiple Myeloma: A Real Life Retrospective Evaluation

Blood, 2016
, Maurizio Zangari, Carolina Schinke
exaly  

Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development

Therapeutic Advances in Hematology, 2015
Yunxin Chen
exaly  

FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy

Oncologist, 2017
Ann Farrell, Rajeshwari Sridhara, Yuan-Li Shen   +2 more
exaly